Nippon Life Ind. (NAM-INDIA)

FairStock Score: 67/100 — STEADY

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Exceptionally high return ratios: ROE 34.26%, ROCE 40.69% reflecting a true asset-light AMC business.
• Near-zero leverage with D/E 0.02 and strong FCF of ₹1,118 Cr supports financial resilience.
• Piotroski score 8/9 and Altman Z-Score 10.22 indicate very low bankruptcy risk and solid operating health.
• High promoter holding of 72.05% aligns management with minority shareholders.
• Consistent scale with 5-year revenue CAGR 12.15% and latest quarter sales of ₹705 Cr.

Concerns

• Profit growth of 7.08% lags revenue growth of 13.47%, showing margin pressure.
• Valuation is demanding: P/E 41.12, P/B 15.60, EV/EBITDA 23.30 with Graham Number ₹184.92 and negative margin of safety.
• DCF intrinsic value ₹939.16 is below market price ₹1,031.25, leaving little cushion.
• Business is market-linked; AMC revenues and AUM can be volatile with equity market cycles.

AI Analysis

I have always said it is far better to buy a wonderful business at a fair price than a fair business at a wonderful price. Nippon Life India is close to a wonderful business. The economics are exceptional: return on equity of 34.26% and return on capital employed of 40.69%, with almost no debt at 0.02 debt-to-equity. This is an asset-light model that generates hard cash—free cash flow of ₹1,118 crore. The Piotroski score of 8 out of 9 confirms the balance sheet is sound. Promoter holding of 72.05% is another comfort; the owners are aligned. But Benjamin Graham taught me that no matter how good the business, paying too much can turn an investment into speculation. At ₹1,031.25, the stock trades at 41.12 times earnings and 15.60 times book value. Graham's number is merely ₹184.92, and even a conservative DCF estimate of ₹939.16 sits below the current price. In other words, the margin of safety is negative—about minus 403% on a Graham basis. Sales have grown at 13.47% and the five-year revenue CAGR is 12.15%, but profit growth is only 7.08%. That gap tells me the company is not converting revenue growth into profit at the same pace. That could be competitive pressure or rising costs. The latest quarter shows sales of ₹705 crore and net profit of ₹404 crore, so the franchise is still performing well. Yet at 1.93% dividend yield, the investor is depending entirely on future growth to justify today's price. This is a quality compounder, a stalwart, not a fast grower. I would love to own it at a more reasonable price. At this price, I would wait and keep my powder dry.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer